Clinical Trials Browser

Phase 3 × Interventional × Aprepitant × Clear all

NCT06007586 2025-12-04

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Phase 3 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vomiting, Endometrial Neoplasms

NCT03808805 2025-12-03

APHYPAP

Phase 3 Completed

Myeloproliferative Disorders

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

401 enrolled 14 charts

Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell

NCT05711823 2024-01-23

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT03674294 2023-02-08

CINV

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

NCT02336750 2022-04-20

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

Phase 3 Completed

Breast Neoplasms

NCT01661335 2021-03-23

Efficacy of Aprepitant (Emend®) in Children

Phase 3 Completed

Nausea, Neoplasms, Vomiting

NCT02161991 2020-03-26

Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT00092196 2017-05-05

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Phase 3 Completed

Breast Neoplasms, Nausea, Vomiting

NCT02979548 2017-01-25

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00572572 2016-04-06

Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors

Phase 3 Completed

69 enrolled 14 charts

Neoplasms, Germ Cell and Embryonal

NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Phase 3 Completed

1,021 enrolled 10 charts

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00869973 2013-01-23

Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients

Phase 3 Terminated

Breast Neoplasms, Vomiting

NCT00571168 2010-01-12

EmNa

Phase 3 Unknown

Multiple Myeloma, Vomiting